Supplemental material
Bioengineered
Volume 12, 2021 - Issue 2
Research Paper
The phosphoinositide 3-kinase inhibitor ZSTK474 increases the susceptibility of osteosarcoma cells to oncolytic vesicular stomatitis virus VSVΔ51 via aggravating endoplasmic reticulum stress
, , , & 
Qian Zhoub Department of Spine Surgery, The First Hospital of Changsha, Changsha, Hunan, ChinaCorrespondence[email protected]
https://orcid.org/0000-0002-0907-0254View further author information
https://orcid.org/0000-0002-0907-0254View further author informationRelated Research Data
The phosphoinositide 3-kinase inhibitor ZSTK474 increases the susceptibility of osteosarcoma cells to oncolytic vesicular stomatitis virus VSV��51 via aggravating endoplasmic reticulum stress
Source:
Taylor & Francis
Linking provided by
